Emil D. Kakkis
2016
In 2016, Emil D. Kakkis earned a total compensation of $4.4M as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $340,320 |
|---|---|
| Option Awards | $2,722,360 |
| Salary | $567,200 |
| Stock Awards | $755,099 |
| Other | $38,383 |
| Total | $4,423,362 |
Kakkis received $2.7M in option awards, accounting for 62% of the total pay in 2016.
Kakkis also received $340.3K in non-equity incentive plan, $567.2K in salary, $755.1K in stock awards and $38.4K in other compensation.
Rankings
In 2016, Emil D. Kakkis' compensation ranked 1,945th out of 14,075 executives tracked by ExecPay. In other words, Kakkis earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,945 out of 14,075 | 86th |
Division Manufacturing | 668 out of 5,486 | 88th |
Major group Chemicals And Allied Products | 188 out of 1,900 | 90th |
Industry group Drugs | 134 out of 1,543 | 91st |
Industry Pharmaceutical Preparations | 107 out of 1,173 | 91st |
Source: SEC filing on April 28, 2017.
Kakkis' colleagues
We found five more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2016.
2016
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2016
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2016
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2016
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2016
Thomas Kassberg
Ultragenyx Pharmaceutical